Teladoc Health, Inc. Common Stock (NY:TDOC)

5.530 +0.010 (+0.18%)

Delayed Quote Updated: 11:01 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teladoc Health, Inc. Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

58 59 Next >

1 Excellent Growth Stock to Buy Near Its 52-Week Low ↗

January 25, 2023

This year can't be much worse than 2022 for this healthcare specialist.

Via The Motley Fool

Is Amazon the Future of Healthcare? ↗

January 25, 2023

The e-commerce titan announced the RxPass subscription for Prime members. What companies will this service disrupt, and can Amazon stock benefit?

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

January 24, 2023

The growth-focused money manager is making moves.

Via The Motley Fool

Teladoc Stock: Buy, Sell, or Hold in 2023? ↗

January 24, 2023

This high-growth stock is making all the right moves.

Via The Motley Fool

Did Teladoc Just Take a Big Step Towards Profitability? ↗

January 24, 2023

Teladoc is winning when it comes to revenue and membership growth -- but profit has been elusive.

Via The Motley Fool

Teladoc Health Releases Annual Corporate Social Responsibility Report

January 23, 2023

Industry leader details new commitments to drive health equity, reports 33% increase in employee volunteerism

From Teladoc Health, Inc.

Via GlobeNewswire

Where Teladoc Health Stands With Analysts ↗

January 18, 2023

Via Benzinga

Why Teladoc Health Stock Was Sliding Today ↗

January 18, 2023

Shares of the telehealth provider fell after management announced layoffs.

Via The Motley Fool

Want to Start 2023 Out Right? Buy These Bargain Growth Stocks ↗

January 20, 2023

These stocks could boost your portfolio over time.

Via The Motley Fool

Why Teladoc Health Stock Fell Again on Thursday ↗

January 19, 2023

The company continues to make investors and pundits more bearish with its latest announcement.

Via The Motley Fool

2 Former Pandemic Darlings Poised To Lead Again ↗

January 19, 2023

As time passes, some of the pandemic darlings will go the way of CMGI and Pets.com after the dot com bubble, while others will rise again to lead the market. So, which two former pandemic darlings may...

Via Talk Markets

Why Is NeuroSense (NRSN) Stock Up 98% Today? ↗

January 19, 2023

NeuroSense (NRSN) stock is taking off on Thursday as investors react to data from a biomarker study concerning Alzheimer's disease (AD).

Via InvestorPlace

Teladoc Layoffs 2023: What to Know About the Latest TDOC Job Cuts ↗

January 19, 2023

Teladoc is trimming its workforce in order to cut costs, but today's TDOC stock traders aren't too pleased with this development.

Via InvestorPlace

Teladoc Health Slashes 300 Redundant Non-Clinician Roles, Reduces Office Spaces To Save Costs ↗

January 18, 2023

Teladoc Health, Inc (NYSE: TDOC) slashed 6% of its workforce and underwent other initiatives during the fourth quarter of 2022 to reduce operating costs.

Via Benzinga

2 Down-on-Their-Luck Stocks That Could Go Parabolic ↗

January 17, 2023

Any bit of good news could send these stocks soaring.

Via The Motley Fool

Is Teladoc Stock a Buy Now? ↗

January 11, 2023

After a horrible 2022, investors are eager to see better days.

Via The Motley Fool

Can Teladoc Prove the Short-Sellers Wrong in 2023? ↗

January 11, 2023

Short interest in the telehealth stock remains high at over 20%.

Via The Motley Fool

Got $1,000? 2 Top Growth Stocks to Buy That Could Double Your Money ↗

January 16, 2023

The new year is here, and it's still a great time to buy amazing companies.

Via The Motley Fool

3 Growth Stocks With More Potential Than Any Cryptocurrency ↗

January 15, 2023

Don't let the crypto winter get you down.

Via The Motley Fool

2 Beaten-Down Cathie Wood Stocks That Could Be Bargain Buys for 2023 ↗

January 15, 2023

Wood is betting on these players for their innovation and high growth potential.

Via The Motley Fool

Teladoc Health: Bull vs. Bear ↗

January 14, 2023

Plus, we've got a look at what's going on with Lululemon and Goldman Sachs.

Via The Motley Fool

Investors Gave These Stocks a Thumbs Down Last Year. Here's Why They Could Win a Thumbs Up in 2023. ↗

January 14, 2023

These stocks have what it takes to climb now -- and well into the future.

Via The Motley Fool

Nasdaq Bear Market: 5 Awe-Inspiring Growth Stocks You'll Regret Not Buying on the Dip ↗

January 14, 2023

These innovative stocks are begging to be bought following a peak decline of 38% in the growth-driven Nasdaq Composite.

Via The Motley Fool

Why Teladoc Health Stock Jumped Today ↗

January 09, 2023

A guidance update lifted investors' spirits.

Via The Motley Fool

Why Shares of Teladoc Health Climbed This Week ↗

January 13, 2023

The telehealth provider increased annual guidance.

Via The Motley Fool

7 Under-the-Radar Growth Stocks With 10% Upside Potential ↗

January 11, 2023

Wall Street sees gains ahead for these under the radar growth stocks that have fallen on hard times coming out of the global pandemic.

Via InvestorPlace

Can Cathie Wood Bounce Back in 2023? ↗

January 11, 2023

Wood sticks by her strategy, no matter what the general market does.

Via The Motley Fool

5 Struggling Stocks to Buy at a Discount ↗

January 10, 2023

These are bargains you won't want to miss.

Via The Motley Fool

There's No 'Real' Competition In The Athleisure Space: Why This Investor Bought Lululemon Stock With Shares Stretched Out ↗

January 09, 2023

Lululemon Athletica Inc (NASDAQ: LULU) shares are on sale Monday after the company narrowed its holiday quarter outlook. Short Hills Capital's

Via Benzinga

Why Teladoc Stock Slumped Today While the Market Soared ↗

January 06, 2023

You'd probably also be glum if someone cut your price target at a double-digit rate.

Via The Motley Fool

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

58 59 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.